- Markets
- Healthcare
- BACPHAR
BACPHAR
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Bacil Pharma do?
Established in 1987, Bacil Pharma Limited is a public company specializing in bulk pharmaceutical and chemical manufacturing, including heavy, medium, and fine chemicals.
Who are the competitors of Bacil Pharma?
Bacil Pharma major competitors are Bandaram Pharma Pack, Sandu Pharmaceutical, Walpar Nutritions, Deccan Health Care, Shelter Pharma, Chandra Bhagat Pharm, Roopa Industries. Market Cap of Bacil Pharma is ₹49 Crs. While the median market cap of its peers are ₹46 Crs.
Is Bacil Pharma financially stable compared to its competitors?
Bacil Pharma seems to be less financially stable compared to its competitors. Altman Z score of Bacil Pharma is 0 and is ranked 8 out of its 8 competitors.
Does Bacil Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Bacil Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Bacil Pharma allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Bacil Pharma balance sheet?
Bacil Pharma balance sheet is weak and might have solvency issues
Is the profitablity of Bacil Pharma improving?
Yes, profit is increasing. The profit of Bacil Pharma is -₹0.06 Crs for Mar 2024, -₹0.1 Crs for Mar 2023 and -₹3.86 Crs for Mar 2022
Is the debt of Bacil Pharma increasing or decreasing?
Yes, The debt of Bacil Pharma is increasing. Latest debt of Bacil Pharma is ₹0.05 Crs as of Sep-24. This is greater than Mar-24 when it was ₹0.05 Crs.
Is Bacil Pharma stock expensive?
There is insufficient historical data to gauge this. Latest PE of Bacil Pharma is 141.3
Has the share price of Bacil Pharma grown faster than its competition?
Bacil Pharma has given better returns compared to its competitors. Bacil Pharma has grown at ~105.15% over the last 1yrs while peers have grown at a median rate of -21.11%
Is the promoter bullish about Bacil Pharma?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Bacil Pharma is 10.6% and last quarter promoter holding is 20.7%
Are mutual funds buying/selling Bacil Pharma?
There is Insufficient data to gauge this.